9 |
GLOBAL HUMAN INSULIN DRUGS MARKET, BY BRAND.......................................................... 73 |
||
• 9.1 |
INTRODUCTION............................................................................................................................................................... 74 |
||
• 9.2 |
INSULIN ANALOGS AND BIOSIMILARS........................................................................................................................... 75 |
||
• 9.2.1 |
LANTUS......................................................................................................................................................... 77 |
||
• 9.2.2 |
NOVORAPID AND NOVOLOG......................................................................................................................... 78 |
||
• 9.2.3 |
HUMALOG..................................................................................................................................................... 79 |
||
• 9.2.4 |
OTHER BRANDS............................................................................................................................................. 80 |
||
• 9.3 |
HUMAN INSULIN BIOLOGICS.......................................................................................................................................... 81 |
||
• 9.3.1 |
ACTRAPID, MIXTARD, AND INSULATARD..................................................................................................... 83 |
||
• 9.3.2 |
HUMULIN....................................................................................................................................................... 84 |
||
• 9.3.3 |
INSUMAN....................................................................................................................................................... 85 |
||
10 |
GLOBAL HUMAN INSULIN MARKET, BY DELIVERY DEVICE..................................................... 86 |
||
• 10.1 |
INTRODUCTION............................................................................................................................................................... 87 |
||
• 10.2 |
HUMAN INSULIN PENS................................................................................................................................................... 88 |
||
• 10.2.1 |
REUSABLE PENS........................................................................................................................................... 89 |
||
• 10.2.2 |
DISPOSABLE PENS........................................................................................................................................ 90 |
||
• 10.3 |
HUMAN INSULIN PEN NEEDLES..................................................................................................................................... 91 |
||
• 10.3.1 |
STANDARD PEN NEEDLES............................................................................................................................. 92 |
||
• 10.3.2 |
SAFETY PEN NEEDLES.................................................................................................................................. 93 |
||
• 10.4 |
HUMAN INSULIN SYRINGES........................................................................................................................................... 94 |
||
11 |
GLOBAL HUMAN INSULIN MARKET, BY APPLICATION............................................................. 95 |
||
• 11.1 |
INTRODUCTION............................................................................................................................................................... 96 |
||
• 11.2 |
TYPE I DIABETES............................................................................................................................................................. 96 |
||
• 11.3 |
TYPE II DIABETES............................................................................................................................................................ 97 |
||
• | |||